Tested lymph surgery for breast-cancer–related arm swelling
Part of Blood & lymphatic clinical trials.
This trial studies a specialized lymph surgery (called VLNT, moving lymph tissue) to treat swelling in an arm caused by breast cancer treatment. It may help reduce lymphedema that doesn’t fully improve with compression and elevation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18–75 and your arm swelling is from past breast cancer treatment
- Your breast cancer treatment was finished at least 3 years ago, and you have no signs of active cancer
- Your lymphedema is mild to early (stage I–II) and it doesn’t fully go away with elevation or compression
- You completed a full lymphedema therapy plan for at least 12 weeks before starting, using compression consistently without major changes
- You can safely undergo surgery and general anesthesia, and you’re able to keep wearing compression as instructed during the study
- You can attend all tests, including possible skin sampling (skin biopsy) and scans before and after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific surgery (a lymph vessel transplant) can reduce upper-arm lymphedema in people who developed swelling after breast cancer treatment. You must already have tried standard therapy and still have persistent, mild-to-moderate swelling.
This study tests a surgical procedure (called supermicrosurgical lymphaticovenous anastomosis, or LVA) that connects tiny lymph vessels to nearby veins. The goal is to prevent arm swelling (lymphedema) in women with breast cancer who are having lymph nodes removed and radiation therapy.
This trial studies a new procedure meant to lower the chance of getting lymphedema (arm swelling) after breast cancer surgery that removes lymph nodes in the armpit. It may help patients reduce the risk of long-term arm swelling, especially after lymph node dissection.
This study tests a medical device (Dayspring Technology) to reduce swelling in the arm caused by breast cancer treatment and lymph surgery. You may be eligible if you have one-sided arm swelling after lymphatic surgery and meet safety checks for the device.
This trial looks at a combined approach to treat chronic lymphedema (long-term arm swelling) after breast cancer treatment. Doctors will use different surgical techniques, alone or together, to see which works best.
This trial tests a comprehensive prevention program to reduce lymphedema—a swelling in the arm—after breast cancer surgery that removes lymph nodes. If you qualify, you'll learn special exercises and care steps to lower your risk.
Hear when a new Lymphedema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.